We are live on ! Find out more
TWST icon

Twist Bioscience

221 hedge funds and large institutions have $2.04B invested in Twist Bioscience in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

48% more call options, than puts

Call options by funds: $5.54M | Put options by funds: $3.73M

21% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 61

8% more funds holding

Funds holding: 204221 (+17)

2% more capital invested

Capital invested by funds: $2.01B → $2.04B (+$36M)

0.34% more ownership

Funds ownership: 103.14%103.48% (+0.34%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
221
Holders Change
+17
Holders Change %
+8.33%
% of All Funds
3.81%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
39
Increased
74
Reduced
61
Closed
19
Calls
$5.54M
Puts
$3.73M
Net Calls
+$1.81M
Net Calls Change
-$2.65M
Name Holding Trade Value Shares
Change
Change in
Stake
State of New Jersey Common Pension Fund D
76
State of New Jersey Common Pension Fund D
New Jersey
$1.86M -$367K -8,643 -14%
Deutsche Bank
77
Deutsche Bank
Germany
$1.76M +$47.7K +1,124 +2%
CGL
78
Clarius Group LLC
Washington
$1.75M
Manulife (Manufacturers Life Insurance)
79
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.75M -$13.5K -318 -0.6%
Qube Research & Technologies (QRT)
80
Qube Research & Technologies (QRT)
United Kingdom
$1.66M +$2M +47,072 New
Russell Investments Group
81
Russell Investments Group
United Kingdom
$1.58M -$433K -10,198 -18%
TI
82
Trexquant Investment
Connecticut
$1.56M +$1.88M +44,210 New
TD Asset Management
83
TD Asset Management
Ontario, Canada
$1.29M
Squarepoint
84
Squarepoint
New York
$1.29M -$906K -21,340 -37%
FM
85
Freemont Management
Switzerland
$1.22M +$191K +4,500 +15%
ETC
86
Exchange Traded Concepts
Oklahoma
$1.21M -$973K -22,914 -40%
TRCT
87
Tower Research Capital (TRC)
New York
$1.18M +$1.16M +27,424 +456%
GC
88
Guggenheim Capital
Illinois
$1.05M +$1.27M +29,857 New
MIM
89
MetLife Investment Management
New Jersey
$1.05M
D.E. Shaw & Co
90
D.E. Shaw & Co
New York
$1M -$3.17M -74,653 -72%
EIM
91
Essex Investment Management
Massachusetts
$993K +$518K +12,194 +76%
Rockefeller Capital Management
92
Rockefeller Capital Management
New York
$956K +$71.5K +1,684 +7%
MAP
93
Moody Aldrich Partners
Massachusetts
$946K +$1.14M +26,852 New
AIG
94
American International Group
New York
$939K +$16K +377 +1%
CFM
95
Comprehensive Financial Management
California
$926K
UBS Group
96
UBS Group
Switzerland
$907K -$606K -14,267 -36%
Mirae Asset Global Investments
97
Mirae Asset Global Investments
South Korea
$881K +$302K +7,112 +40%
DekaBank Deutsche Girozentrale
98
DekaBank Deutsche Girozentrale
Germany
$877K +$486K +11,450 +85%
SSA
99
Schonfeld Strategic Advisors
New York
$864K -$416K -9,802 -29%
SIA
100
Sit Investment Associates
Minnesota
$830K +$221K +5,200 +28%

TWST Hedge Fund Activity: Q3 2022 in Review

221 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2022, worth a combined $2.04B — up 1.8% from $2.01B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new TWST positions and 19 closed out — a net gain of 20 holders — while 74 added to existing stakes and 61 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $65.3M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $54.5M sold.

  • 221 institutional investors held Twist Bioscience (TWST) as of Q3 2022, up from 204 in Q2 2022.
  • Funds reported $2.04B of Twist Bioscience stock for Q3 2022, up 1.8% quarter-over-quarter.
  • 39 funds opened new Twist Bioscience positions in Q3 2022 and 19 closed out, a net change of +20 holders.
  • The largest Twist Bioscience buyer in Q3 2022 was VOYA Investment Management, an estimated $65.3M added.
  • The largest Twist Bioscience seller in Q3 2022 was Allianz Asset Management, an estimated $54.5M sold.

Based on aggregated 13F filings for Q3 2022.